Q1 FY 20 Performance Update

Our Quality Journey We are committed to excellence in quality and being best in class U.S. FDA Audit Updates Sites Previously on Warning Letter CTO 6: Submitted all compliance responses; Awaiting re-inspection FTO 7 Sterile Plant: Received EIR, status changed to VAI Update on recently audited sites CTO 2: Received Form 483 with 5 observations pam-pac Sites in receipt of EIR & considered compliant FTO 3 FTO-PU 1 FTO-PU 2 Shreveport CTO - 1 CTO -3 CTO-5 CTO - SEZ Mexico Mirfield CPS - TDC In addition, our sites have been approved by regulators from ~20 countries 33333333 23242 3333 core rece Occre PROPRIETARY

View entire presentation